Showing 861 - 880 results of 101,291 for search '(( 5 ((mean decrease) OR (we decrease)) ) OR ( 5 ((a decrease) OR (nn decrease)) ))', query time: 0.93s Refine Results
  1. 861
  2. 862
  3. 863
  4. 864
  5. 865
  6. 866
  7. 867

    Increases in the gain of Ia afferent feedback (i.e., larger presynaptic control level) decrease low-frequency force variability (1-5 Hz) while they increase physiological tremor (5... by Akira Nagamori (4743981)

    Published 2018
    “…<p>All of the dependent variables are normalized to their respective mean values at the presynaptic control level of -0.5. …”
  8. 868

    Tetrahydrohyperforin Inhibits the Proteolytic Processing of Amyloid Precursor Protein and Enhances Its Degradation by Atg5-Dependent Autophagy by Viviana A. Cavieres (500139)

    Published 2015
    “…We show herein that IDN5706 decreases the levels of ER degradation enhancer, mannosidase alpha-like 1 (EDEM1), a key chaperone related to endoplasmic-reticulum-associated degradation (ERAD). …”
  9. 869
  10. 870
  11. 871
  12. 872
  13. 873
  14. 874
  15. 875

    Flow chart of the study procedures. by Kazuhiko Ikeuchi (9234268)

    Published 2023
    “…Pre-treatment spontaneous decrease of RPR titer was associated with a slower decrease in post-treatment RPR titer.…”
  16. 876
  17. 877
  18. 878

    DNA methylation of RALBP1 is associated with a decrease in gene expression. by Tina Rönn (253292)

    Published 2013
    “…<p>A CpG site in the promoter region of <i>RALBP1</i> showed A) increased DNA methylation in response to exercise as well as B) a decrease in mRNA expression. …”
  19. 879
  20. 880

    Decreased Brain Levels of Vitamin B12 in Aging, Autism and Schizophrenia by Yiting Zhang (391974)

    Published 2016
    “…Vitamin B<sub>12</sub> (cobalamin, Cbl) exists in multiple forms, including methylcobalamin (MeCbl) and adenosylcobalamin (AdoCbl), serving as cofactors for MS and methylmalonylCoA mutase, respectively. We measured levels of five Cbl species in postmortem human frontal cortex of 43 control subjects, from 19 weeks of fetal development through 80 years of age, and 12 autistic and 9 schizophrenic subjects. …”